A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGF3 and their receptors in cultured uterine leiomyoma cells

By Wang Jiayin   Ohara Noriyuki   Wang Zhuo   Chen Wei   Morikawa Akira   Sasaki Hiroko   DeManno Deborah A.   Chwalisz Kristof   Maruo Takeshi  

Human Reproduction, Vol. 21, Iss. 7, 2006-07 ,pp. : 1869-1877

Oxford University Press

Access to resources Recommend Favorite

The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata

By Williams A.R.W.   Critchley H.O.D.   Osei J.   Ingamells S.   Cameron I.T.   Han C.   Chwalisz K.  

Human Reproduction, Vol. 22, Iss. 6, 2007-06 ,pp. : 1696-1704

Oxford University Press

Access to resources Recommend Favorite

Progesterone and progesterone receptor modulator in uterine leiomyoma growth

By Maruo Takeshi  

Gynecological Endocrinology, Vol. 23, Iss. 4, 2007-04 ,pp. : 186-187

Informa Healthcare

Access to resources Recommend Favorite

Effects of projective bone area size of the spine on bone density and the diagnosis of osteoporosis in healthy pre-menopausal women in China

By Wu X-P   LIAO E-Y   DAI R-C   Luo X-H   Zhang H  

British Journal of Radiology, Vol. 76, Iss. 907, 2003-07 ,pp. : 452-458

British Institute of Radiology

Access to resources Recommend Favorite

Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro

By Liu Jin   Matsuo Hiroya   Xu Qin   Chen Wei   Wang Jiayin   Maruo Takeshi  

Human Reproduction, Vol. 22, Iss. 5, 2007-05 ,pp. : 1253-1259

Oxford University Press

Access to resources Recommend Favorite